BC Platforms, a world leader in secure genomic data management and analytics, has announced the incorporation of new Ontology Browser and Data Visualization Dashboard to its widely used BC|INSIGHT data management platform. This new capability is being utilized by pharmaceutical companies participating in the UK Biobank project. It will also bring additional value to over 70 major organizations globally already using the BC|INSIGHT system, as well as potential new clients.
BC Platforms, founded in 1997 from an MIT Whitehead project spinoff, is in the business of powerful genomic data management and analysis solutions. The company operates a Global Network of Biobanks known as BCRQUEST.COM, a streamlined solution for secure data sharing, analytics and governance, enabling greater collaboration for scientific innovation.
BC Platforms has global operations with its headquarters in Basel, Switzerland, research and development in Helsinki, Finland, and sales and marketing in London, Boston, and Vancouver. The company’s vision is to build the world’s leading analytics platform for healthcare and industry by 2020.
BC|INSIGHT represents the largest variety of commonly used analytical and bioinformatics tools across easily accessible user interfaces with customizable workflows. Its primary role within BC Platforms’ offering is in data management capabilities, including automated error checking and quality control, scalable genomic data analysis using peer-reviewed bioinformatics tools, graphical visualization of datasets and results, and workflow design applications.
The new Ontology Browser and Data Visualization Dashboard provide users with a visual and contextual overview of massive datasets, customizable to various researcher needs. The addition of these features will further complement BC Platforms’ tertiary analytics tools, enabling scalable phenotypic and genetic data exploration for streamlined patient cohort identification and data organization. These tools are integrated in a user-friendly modular solution for harmonized clinical and genetic data management and bioinformatics applications across research groups.
“We are delighted to launch this new capability to further expand our customizable, modular offering, including genomic data management tools and a clinical reporting hub to support precision medicine. Our platform provides an unrivalled toolkit for analyzing hundreds of thousands of subjects securely at high speed. Our new capability for visualizing and contextualizing immense numbers of phenotypic and genomic datasets brings new value to our legacy offering.” – Tero Silvola, CEO of BC Platforms